Ocugen, Inc. (OCGN)
1.03
+0.03
(+3.00%)
USD |
NASDAQ |
Oct 02, 11:13
Ocugen Total Return Price : 1.03 for Oct. 2, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 01, 2026 | 1.00 |
| September 30, 2026 | 1.03 |
| September 29, 2026 | 1.09 |
| September 28, 2026 | 1.03 |
| September 25, 2026 | 1.02 |
| September 24, 2026 | 1.00 |
| September 23, 2026 | 1.00 |
| September 22, 2026 | 1.04 |
| September 21, 2026 | 1.03 |
| September 18, 2026 | 1.06 |
| September 17, 2026 | 1.03 |
| September 16, 2026 | 0.9984 |
| September 15, 2026 | 0.9935 |
| September 14, 2026 | 1.06 |
| September 11, 2026 | 1.02 |
| September 10, 2026 | 1.025 |
| September 09, 2026 | 1.065 |
| September 08, 2026 | 1.33 |
| September 04, 2026 | 1.36 |
| September 03, 2026 | 1.35 |
| September 02, 2026 | 1.32 |
| September 01, 2026 | 1.33 |
| August 31, 2026 | 1.33 |
| August 28, 2026 | 1.32 |
| August 27, 2026 | 1.37 |
| Date | Value |
|---|---|
| August 26, 2026 | 1.41 |
| August 25, 2026 | 1.40 |
| August 24, 2026 | 1.36 |
| August 21, 2026 | 1.39 |
| August 20, 2026 | 1.39 |
| August 19, 2026 | 1.48 |
| August 18, 2026 | 1.34 |
| August 17, 2026 | 1.375 |
| August 14, 2026 | 1.35 |
| August 13, 2026 | 1.35 |
| August 12, 2026 | 1.40 |
| August 11, 2026 | 1.37 |
| August 10, 2026 | 1.31 |
| August 07, 2026 | 1.28 |
| August 06, 2026 | 1.24 |
| August 05, 2026 | 1.28 |
| August 04, 2026 | 1.31 |
| August 03, 2026 | 1.25 |
| July 31, 2026 | 1.23 |
| July 30, 2026 | 1.26 |
| July 29, 2026 | 1.19 |
| July 28, 2026 | 1.24 |
| July 27, 2026 | 1.26 |
| July 24, 2026 | 1.21 |
| July 23, 2026 | 1.27 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Anika Therapeutics, Inc. | 19.31 |
| Gilead Sciences, Inc. | 144.86 |
| MannKind Corp. | 3.83 |
| Vertex Pharmaceuticals, Inc. | 502.66 |